Skip to content

Agilon Health AGL Common Stock

Common Stock at other companies

Astrana Health logo
Astrana HealthASTH
$49K0.0%
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
1B0.0%
Alignment Healthcare logo
Alignment HealthcareALHC
1B0.0%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$10
Centene logo
CenteneCNC
$1M0.0%
National Healthcare logo
National HealthcareNHC
$156K+1.3%

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.86B-92.6%
Enterprise value$1.69B-103%
P/S0.3×-3.9×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's common stock?
Agilon Health (AGL) reported common stock of 2B in Q1 2026.
How has Agilon Health's common stock changed year-over-year?
Agilon Health's common stock decreased by 0.0% year-over-year, from 2B to 2B.
What is the long-term trend for Agilon Health's common stock?
Over 5 years (2020 to 2025), Agilon Health's common stock has grown at a 280.9% compound annual growth rate (CAGR), from 2.5M to 2B.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).